Your session is about to expire
← Back to Search
Radioactive Agent for Cancer (NeoRay Trial)
NeoRay Trial Summary
This trial is testing a new treatment for cancer that uses a radioactive agent. They will study how well it works and how safe it is.
NeoRay Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNeoRay Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NeoRay Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any mental or physical health conditions that could affect the study.I have a metastatic tumor likely to overexpress GRPR and my kidney function is moderately impaired.I have been diagnosed with GIST.I am an adult with advanced or metastatic cancer.I have breast cancer, tried at least 2 hormone therapies and 1 chemotherapy, with no standard treatment left.I can take care of myself and am up and about more than half of the day.My breast cancer is HR-positive, mostly ER-positive, and not HER2-positive.My scans show a tumor that absorbs a specific tracer.I have had or currently have pancreatitis.I can take care of myself but might not be able to do heavy physical work.I am a woman able to have children and am not using strong birth control methods.I am receiving [223Ra]-therapy for widespread bone or bone-marrow cancer.I have breast, lung, prostate cancer, GIST, or GBM.I have heart problems that affect my daily activities.I have prostate cancer.You have not taken any experimental drugs within the last 30 days before agreeing to participate in this study.I have breast, lung, prostate cancer, GIST, or GBM.My cancer has spread, shows GRPR overexpression, and I have moderate kidney issues.I have had 2 hormone therapies and 1 chemotherapy for my advanced breast cancer.My breast cancer is HR-positive, ER > 10%, and HER-2 negative.You must give permission by signing a form before joining the study.My diabetes is not well-controlled, or I have high blood sugar levels.My side effects from previous cancer treatments are mild, except for hair loss.I have at least one tumor that can be measured on scans.I have not had cancer treatment within the specified time.I have been diagnosed with GIST.I have prostate cancer.I have issues controlling my urine or emptying my bladder.I have no other cancer types except the one being treated, with some exceptions.You are pregnant or currently breastfeeding.I have had radiation therapy to over 25% of my bone marrow.I haven't had radiopharmaceutical therapy recently.There are no suitable standard treatments for my condition.My cancer can be seen on a special scan and it may be in my bones.
- Group 1: Phase IIa
- Group 2: Phase I Cohort VII
- Group 3: Phase I Cohort I
- Group 4: Phase I Cohort II
- Group 5: Phase I Cohort III
- Group 6: Phase I Cohort IV
- Group 7: Phase I Cohort V
- Group 8: Phase I Cohort VI
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many patients are included in this research project?
"That is accurate. The website clinicaltrials.gov has information indicating that the trial is looking for 86 individuals to participate at 4 different locations. The first posting was on 7/24/2019, with the most recent update being 9/12/2022."
What are the precedent studies for [177Lu]-NeoB?
"Currently, there are 33 ongoing studies observing the effects of [177Lu]-NeoB. Of these, 3 are large-scale Phase 3 clinical trials. The majority of research surrounding this treatment is based in Perth, Western Australia; however, 241 different locations worldwide are running some form of study regarding [177Lu]-NeoB."
Are people still being recruited for this clinical trial?
"The clinical trial is actively recruiting patients and has been since it was first posted on 7/24/2019. 86 individuals are needed at 4 sites, as per the latest data from clinicaltrials.gov"
Share this study with friends
Copy Link
Messenger